Notice of Effectiveness (effect)
01 Ottobre 2018 - 12:36PM
Edgar (US Regulatory)
|
UNITED STATES
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
Washington, D.C. 20549
|
NOTICE OF EFFECTIVENESS
|
|
|
|
Effective Date:
|
September 28,
2018
|
|
Form:
|
S-1
|
|
CIK:
|
0001533040
|
|
Company Name:
|
RXi Pharmaceuticals Corp
|
|
File Number:
|
333-227173
|
Grafico Azioni RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni RXI Pharmaceuticals Corporation (NASDAQ:RXII)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Rxi Pharmaceuticals Corp. (MM) (NASDAQ): 0 articoli recenti
Più Rxi Pharmaceuticals Corp Articoli Notizie